New York State Common Retirement Fund Halozyme Therapeutics, Inc. Transaction History
New York State Common Retirement Fund
- $74.6 Billion
- Q4 2024
A detailed history of New York State Common Retirement Fund transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 368,010 shares of HALO stock, worth $21.8 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
368,010
Previous 769,504
52.18%
Holding current value
$21.8 Million
Previous $44 Million
60.05%
% of portfolio
0.02%
Previous 0.06%
Shares
30 transactions
Others Institutions Holding HALO
# of Institutions
550Shares Held
124MCall Options Held
668KPut Options Held
259K-
Black Rock Inc. New York, NY17.6MShares$1.04 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$786 Million0.01% of portfolio
-
State Street Corp Boston, MA7.18MShares$425 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.17MShares$247 Million4.34% of portfolio
-
Bank Of America Corp Charlotte, NC3.45MShares$204 Million0.01% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.24B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...